Ordinary Rebalance | Solactive Cure, Health and Wellbeing Index | Effective Date 2nd November 2023
In the ordinary rebalance, the following composition will be implemented effective open 02.11.2023:
ABBVIE INC |
ALLIANZ SE |
AMGEN INC |
ASSICURAZIONI GENERALI SPA |
AVIVA PLC |
AXA SA |
BRISTOL-MYERS SQUIBB CO |
CLOROX COMPANY |
CVS HEALTH CORP |
ESSITY AB CLASS B |
FRESENIUS SE & CO KGAA |
GILEAD SCIENCES INC |
GSK PLC |
KIMBERLY-CLARK CORP |
KONINKLIJKE PHILIPS NV |
LEGAL & GENERAL GROUP PLC ORD |
MEDTRONIC PLC |
MERCK & CO. INC. |
NOVARTIS AG |
PFIZER INC |
RECKITT BENCKISER GROUP PLC |
ROCHE HOLDING AG |
ROYALTY PHARMA PLC- CL A |
SANOFI SA |
SMITH & NEPHEW PLC |
SWISS RE AG |
UNILEVER PLC |
VIATRIS INC |
WALGREENS BOOTS ALLIANCE INC |
ZURICH INSURANCE GROUP AG |